CERS CERUS CORP
Health Care · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about CERUS CORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 3 reports on CERS from 3 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Mark Massaro | Buy | 14 Aug 2026 | 4.00 USD |
| Craig-Hallum | William B Bonello | Buy | 3 Mar 2026 | 5.00 USD |
| Freedom Capital Markets | Ilya Zubkov | Buy | 20 Aug 2026 | 6.50 USD |
| TD Cowen | Joshua T Jennings | Buy | 27 May 2026 | 5.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 30 Apr 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.